Blossom Pharmaceuticals is recalling 133,410 units of various over-the-counter drug products, including zinc oxide ointments, antifungal creams, skin barriers, and enemas. The recall was initiated due to deviations from Current Good Manufacturing Practice (cGMP) regulations, which means the facility's quality and safety standards did not meet FDA requirements. These products are sold under several brand names including Dynarex, WeCare, Nivagen, and Globe.
Failure to follow manufacturing quality standards can result in products that are contaminated, ineffective, or contain incorrect ingredient levels. This poses a health risk to consumers using these products for skin protection, wound care, or as laxatives.
You have 2 options:
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.